首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1562408

到 2030 年歐洲腸外營養市場預測 - 區域分析 - 按營養類型和最終用戶

Europe Parenteral Nutrition Market Forecast to 2030 - Regional Analysis - by Nutrient Type and End User

出版日期: 2024年07月04日 | 出版商:

The Insight Partners | 英文 90 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年歐洲腸外營養市場價值為24.0463億美元，預計到2030年將達到39.5807億美元；預計2022年至2030年複合年成長率為6.4%。

營養不良和早產病例激增推動歐洲腸外營養市場

營養不良包括營養不良、超重或肥胖、維生素或礦物質不足，以及因不良飲食而患有非傳染性疾病。根據世界衛生組織 (WHO) 的資料，到 2021 年，約 19 億成年人超重或肥胖，而 4.62 億人體重不足。中長期缺乏營養豐富的食物，導致4,500 萬人被浪費（對於身高而言太瘦）。此外，約 45% 的 5 歲以下兒童死亡與營養不良有關。根據聯合國兒童基金會2022年7月的資料，營養不良發生率從2019年的8.0%增加到2020年的9.3%； 2021年進一步躍升至9.8%。

根據歐洲專業營養研究，2019 年歐洲約 40% 的住院成人患者營養不良。英國的醫院和家庭護理機構遭受營養不良。根據需要透過腸外方法提供營養支持是治療大多數營養不良病例的重要且適當的方法。

早產是指嬰兒在非常早期的階段出生，也就是在懷孕37週之前出生。根據世界衛生組織 2023 年發布的資料，2020 年全球報告了約1,340 萬早產（超過十分之一）。 %。大量早產兒體重過輕，免疫力不發達，導致他們的生命處於危險之中。早產兒優選腸外營養，因為吸吮或吞嚥困難是未成熟分娩的併發症，或是神經肌肉、心臟或其他疾病所致。當出生後無法透過腸內途徑安全滿足估計的能量和營養需求時，腸外營養（PN）是早產兒和嬰兒常規營養護理的一部分。

因此，兒童和成人營養不良的巨大負擔以及大量早產推動了對腸外營養配方和產品的需求，從而推動了市場。

歐洲腸外營養市場概況

在德國，有幾起與超重問題、肥胖和營養不良有關的案例。根據羅伯特科赫研究所的數據，到 2022 年，大約三分之二的男性和一半以上的女性超重。有活動性腫瘤的患者往往缺乏足夠的食物；因此，腸外和腸內營養用於預防或減少進行性體重減輕。德國科學醫學會協會表示，患有嚴重胃腸道缺陷（例如放射性腸炎）的患者可以從腸外營養中受益。在大多數情況下，人工營養可以穩定或增加體重和體脂肪量。

而且，德國幽門螺旋桿菌感染發生率較高，是胃癌發生的重要原因。根據臨床微生物學和感染雜誌 (ELSEVIER) 的一項研究 (2020)，幽門螺旋桿菌感染了德國約 25% 的總人口，並引起胃炎，並進一步併發胃腺癌。此外，德國的胃癌發生率很高，這促進了該國的診斷程序。根據國際癌症研究機構的最新資料，德國胃癌的年齡標準化發生率為每10萬人中7人，粗率為18.29。上述因素正在推動德國腸外營養市場的發展。

歐洲腸外營養市場收入及 2030 年預測（百萬美元）

歐洲腸外營養市場細分

歐洲腸外營養市場根據營養素類型、最終用戶和國家進行細分。根據營養素類型，歐洲腸外營養市場分為單劑量胺基酸溶液、腸外脂肪乳、碳水化合物、微量元素、維生素和礦物質。 2022 年，單劑量胺基酸溶液細分市場佔據最大市場佔有率。

依最終用戶分類，歐洲腸外營養市場分為醫院、診所等。 2022 年，醫院細分市場佔據最大的市場佔有率。

根據國家/地區，歐洲腸外營養市場分為以下幾個部分。 2022年，德國在歐洲腸外營養市場佔有率中佔據主導地位。

ICU Medical Inc、Grifols SA、輝瑞公司、大塚製藥有限公司、百特國際公司、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd 和 Vifor Pharma Management AG 是歐洲腸外營養市場的一些領先參與者。

Malnutrition includes being undernourished, overweight or obese, having inadequate vitamins or minerals, and having a non-communicable disease due to a bad diet. As per World Health Organization (WHO) data, ~1.9 billion adults were overweight or obese, whereas 462 million were underweight in 2021. Additionally, 39 million children under the age of 5 were overweight, 149 million had stunted growth and development as a result of a chronic lack of nutrient-rich food in their diets, and 45 million were wasted (too thin for height). Furthermore, ~45% of deaths among children aged less than 5 are associated with undernutrition. As per the July 2022 data of the United Nations International Children's Emergency Fund (UNICEF), the prevalence of undernourishment reached 9.3% in 2020 from 8.0% in 2019; it further jumped to 9.8% in 2021.

According to a Specialized Nutrition Europe study, ~40% of hospitalized adult patients were malnourished in Europe in 2019. As per a study titled "A multi-centre survey on hospital malnutrition," published in 2021, approximately 11-45% of patients in hospitals and home care settings in England suffered from malnutrition. Nutritional support delivered through parenteral methods, depending on the need, is an important and appropriate way of treating most malnutrition cases.

Preterm birth refers to a baby being born at a significantly early stage, i.e., before the completion of 37 weeks of pregnancy. As per the WHO data published in 2023, ~13.4 million preterm births (more than 1 in 10 births) were reported worldwide in 2020. On average, 12% of babies in low-income countries are born too early, compared to 9% in high-income countries. A large number of premature babies suffer from low weight and undeveloped immunity, which puts their lives at risk. Parenteral nutrition is preferred in preterm infants due to sucking or swallowing difficulties as a complication of an immature birth or due to neuromuscular, heart, or other disorders. When estimated energy and nutritional requirements cannot be safely met by enteral route right after birth, parenteral nutrition (PN) is part of the routine nutrition care for premature neonates and infants.

Thus, the huge burden of malnutrition in children and adults and the high number of preterm births drive the demand for parenteral nutrition formulae and products, which drives the market.

Europe Parenteral Nutrition Market Overview

In Germany, there are several cases related to overweight issues, obesity, and malnutrition. According to the Robert Koch Institute, approximately two-thirds of men and over half of women were overweight in 2022. Nutritional deficiencies lead to unfavorable outcomes and lower quality of life in patients with malignancies. Patients with active tumors often lack sufficient food; hence, parenteral and enteral nutrition is used to prevent or reduce progressive weight loss. According to the Association of the Scientific Medical Societies in Germany, patients with severe gastrointestinal defects, such as radiation enteritis, can benefit from parenteral nutrition. In most cases, artificial nutrition stabilizes or increases body weight and body fat mass.

Moreover, the incidence of H. pylori infection in Germany is high, which is a significant cause of gastric cancer. According to a study (2020) in the Clinical Microbiology and Infection Journal (ELSEVIER), Helicobacter pylori infected ~25% of the total population in Germany and caused gastritis that becomes more complicated with gastric adenocarcinoma. Furthermore, Germany has a significant incidence rate of stomach cancer, which promotes diagnostic procedures in the country. According to the latest data from the International Agency for Research on Cancer, the estimated age-standardized incidence rate for stomach cancer in Germany is 7 per 100,000, and the crude rate is 18.29. The abovementioned factors are driving the parenteral nutrition market in Germany.

Europe Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

Europe Parenteral Nutrition Market Segmentation

The Europe parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the Europe parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.

By end user, the Europe parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe parenteral nutrition market is segmented into s. Germany dominated the Europe parenteral nutrition market share in 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the Europe parenteral nutrition market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Parenteral Nutrition Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Gastrointestinal Diseases
- 4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
- 4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
- 4.3.1 New Product Developments by Companies
4.4 Future Trends
- 4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis

5. Parenteral Nutrition Market - Europe Market Analysis

5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

6. Europe Parenteral Nutrition Market Analysis - by Nutrient Type

6.1 Overview
6.2 Single Dose Amino Acid Solution
- 6.2.1 Overview
- 6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
- 6.3.1 Overview
- 6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
- 6.4.1 Overview
- 6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
- 6.5.1 Overview
- 6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
- 6.6.1 Overview
- 6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Parenteral Nutrition Market Analysis - by End User

7.1 Overview
7.2 Hospitals
- 7.2.1 Overview
- 7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
- 7.3.1 Overview
- 7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Parenteral Nutrition Market - Country Analysis

8.1 Europe
- 8.1.1 Europe: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
  - 8.1.1.1 Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.1 Overview
    - 8.1.1.1.2 Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.3 Germany: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.1.4 Germany: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.2 United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.1 Overview
    - 8.1.1.2.2 United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.3 United Kingdom: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.2.4 United Kingdom: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.3 France: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.1 Overview
    - 8.1.1.3.2 France: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.3 France: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.3.4 France: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.4 Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.4.1 Overview
    - 8.1.1.4.2 Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.4.3 Italy: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.4.4 Italy: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.5 Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.5.1 Overview
    - 8.1.1.5.2 Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.5.3 Spain: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.5.4 Spain: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.6 Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.6.1 Overview
    - 8.1.1.6.2 Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.6.3 Rest of Europe: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.6.4 Rest of Europe: Parenteral Nutrition Market Breakdown, by End User

9. Industry Landscape

9.1 Overview
- 9.1.1 Overview

10. Company Profiles

10.1 ICU Medical Inc
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Grifols SA
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Pfizer Inc
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Baxter International Inc
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 B Braun SE
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Fresenius Kabi AG
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Vifor Pharma Management AG
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Aculife Healthcare Pvt Ltd
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments

11. Appendix

11.1 About The Insight Partners
11.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Parenteral Nutrition Market Segmentation
Table 2. Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 3. Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 4. United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 5. United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. France: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 7. France: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 8. Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 9. Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 10. Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 11. Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 13. Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 14. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 15. Glossary of Terms, Parenteral Nutrition Market

List Of Figures

Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
Figure 16. Europe: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 18. United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 19. France: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 20. Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 21. Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 22. Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)